サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1425001

疾病管理・予防ワクチン市場：製品タイプ別、投与経路別、適応症別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年予測

Disease Control And Prevention Vaccine Market, By Product Type, By Route of administration, By Indication, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 265 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.98円
疾病管理・予防ワクチン市場：製品タイプ別、投与経路別、適応症別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年予測
出版日: 2024年02月07日
発行: AnalystView Market Insights
ページ情報: 英文 265 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

疾病管理・予防ワクチン市場規模は2023年に512億1,030万米ドルとなり、2024年から2032年にかけてCAGR 10.5%で拡大する見込みです。

疾病管理・予防ワクチン市場-市場力学

世界の感染症罹患率の上昇とワクチンの採用が、疾病管理・予防ワクチン市場の拡大を促進すると予測されます。

感染症の世界の発生率は上昇傾向にあり、ワクチンの使用は感染症の蔓延を抑制・予防する上で重要な役割を果たすと期待されています。ワクチンは公衆衛生を守る上で極めて重要であり、その重要性に対する認識が高まるにつれ、世界中でワクチン接種プログラムの採用が増加しています。政府、ヘルスケア組織、個人は、感染症の負担から地域社会を守るワクチンの価値を認識しています。歴史を通じて、感染症は病気と死の両面で計り知れない苦しみをもたらしてきました。疾病管理予防センターによると、感染症や寄生虫症で内科を受診した患者数は1,020万人、これらの病気を主な診断とする救急外来を受診した患者数は380万人でした。現在進行中のワクチン技術の研究開発は、市場成長の有望な見通しとなっています。しかし、厳しい規制プロセスが疾病管理・予防ワクチン市場の拡大に課題をもたらす可能性があることには注意が必要です。

疾病管理・予防ワクチン市場-主要インサイト

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024-2032年）に約10.5%のCAGRで毎年成長すると予測されています。

製品タイプ別では、2023年には弱毒化ワクチンが最大の市場シェアを占めると予測されています。

投与経路別では、2023年には注射剤が主要タイプとなっています。

適応症別では、2023年には感染症が主要タイプとなっています。

地域別では、北米が2023年の売上高でトップ

疾病管理・予防ワクチン市場-セグメンテーション分析：

世界の疾病管理・予防ワクチン市場は、製品タイプ、投与経路、適応症、地域に基づいて細分化されます。

市場は製品タイプにより4つのカテゴリーに分けられる：生ワクチン、不活化ワクチン、組み換えワクチン、トキソイドワクチンです。市場の大部分を占めるのは弱毒化ワクチンです。顕著な有効性で知られるこれらのワクチンは、自然感染を忠実に模倣し、強固で長期にわたる免疫を提供します。

市場は投与経路によって2つのカテゴリーに分けられる：経口剤と注射剤です。市場の大部分を占めるのは注射剤です。注射用ワクチンは、一般的に筋肉内（IM）または皮下（SC）注射によって投与され、免疫系を刺激して免疫反応を起こします。

市場は適応症によって2つのカテゴリーに分けられる：感染症、がん、その他の適応症です。感染症分野は市場に大きな影響力を持っています。多くの国では、感染症の蔓延を抑制するために予防接種プログラムを実施しています。これらのプログラムには、多くの場合、小児期の定期予防接種と特定集団を対象とした予防接種が含まれます。

疾病管理・予防ワクチン市場-地理的洞察

地理的に、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカなど様々な地域に広がっています。これらの地域は、事業活動を行っている国に基づいてさらに区分されます。予測期間中、市場成長を牽引するのは北米であると予想されるが、これは主に高度先進技術の利用可能性と革新的ワクチンの開発増加によるものです。北米、特に米国は、高度なヘルスケアインフラと研究能力で有名です。この地域には数多くの製薬会社やバイオテクノロジー企業があり、研究開発に多額の投資を行っているため、ワクチン製造のための最先端技術が開発されています。2022年末までに、米国はヘルスケアに4兆5,000億米ドルを費やすと予測されており、世界全体で最もヘルスケア支出が多い国となっています。米国のヘルスケアに関する最新のデータや報告書によると、2021年の同国全体の支出は4兆3,000億米ドルに達し、GDPの18.5％を占めると推定されています。欧州は、主に疾病負担の増加により、予測期間中の市場成長において第2位の地域を占めています。

疾病管理・予防ワクチン市場-競合情勢：

疾病管理・予防ワクチン市場には、さまざまな疾病と闘うためにさまざまな組織や企業によって開発された幅広いワクチンが含まれます。ワクチンの進歩に貢献した著名な機関としては、世界保健機関（WHO）、国立衛生研究所（NIH）、民間団体などが挙げられます。近年、前例のない規模の感染症が出現しているため、ワクチン開発者、規制当局、保健当局、政治関係者にとって新たな課題となっています。ワクチンの製造と流通は複雑なプロセスであり、臨床開発、緊急使用承認、ワクチンの安全性監視、ウイルス亜種のサーベイランスなど、スピードと慎重な配慮の両方が必要です。中低所得国におけるワクチンへのアクセスとワクチン接種の取り組みを優先することは極めて重要です。ワクチン産業は製薬産業に比べれば小規模ですが、着実に成長しています。ワクチン産業に属する企業は、ワクチンの研究、開発、製造、販売、マーケティング、流通に従事しており、その収益は主にワクチン製品の販売によるものです。

目次

第1章 疾病管理・予防ワクチン市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 疾病管理・予防ワクチンの主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 疾病管理・予防ワクチン産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 疾病管理・予防ワクチン市場：COVID-19の影響分析

  • プレ新型コロナウイルス感染症の影響分析
  • ポスト新型コロナウイルス感染症の影響分析

第6章 疾病管理・予防ワクチン市場情勢

  • 疾病管理・予防ワクチン市場シェア分析、2023年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 疾病管理・予防ワクチン市場：製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • 弱毒化生ワクチン
    • 不活化ワクチン
    • 組換えワクチン
    • トキソイドワクチン

第8章 疾病管理・予防ワクチン市場：投与経路別

  • 概要
    • 投与経路別セグメントシェア分析
    • 経口
    • 注射

第9章 疾病管理・予防ワクチン市場：適応症別

  • 概要
    • 適応症別セグメントシェア分析
    • 感染症
    • がん
    • その他の適応症

第10章 疾病管理・予防ワクチン市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 疾病管理・予防ワクチン産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Merck &Co. GlaxoSmithKline plc.
    • Sanofi, AstraZeneca PLC
    • Pfizer Inc.
    • Astellas Pharma Inc.
    • Sinovac Biotech Ltd.
    • Daiichi Sankyo
    • Serum Institute of India Pvt. Ltd.

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Disease Control And Prevention Vaccine Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Disease Control And Prevention Vaccine Market, by Product Type 2019-2032 (USD Million)
  • TABLE Disease Control And Prevention Vaccine Market: Route of administration Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Route of administration
  • TABLE Global Disease Control And Prevention Vaccine Market, by Route of administration 2019-2032 (USD Million)
  • TABLE Disease Control And Prevention Vaccine Market: Indication Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Disease Control And Prevention Vaccine Market, by Indication 2019-2032 (USD Million)
  • TABLE Disease Control And Prevention Vaccine Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Disease Control And Prevention Vaccine Market, by Region 2019-2032 (USD Million)
  • TABLE North America Disease Control And Prevention Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Disease Control And Prevention Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Disease Control And Prevention Vaccine Market, by Route of administration, 2019-2032 (USD Million)
  • TABLE North America Disease Control And Prevention Vaccine Market, by Indication, 2019-2032 (USD Million)
  • TABLE Europe Disease Control And Prevention Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Disease Control And Prevention Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Disease Control And Prevention Vaccine Market, by Route of administration, 2019-2032 (USD Million)
  • TABLE Europe Disease Control And Prevention Vaccine Market, by Indication, 2019-2032 (USD Million)
  • TABLE Asia Pacific Disease Control And Prevention Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Disease Control And Prevention Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Disease Control And Prevention Vaccine Market, by Route of administration, 2019-2032 (USD Million)
  • TABLE Asia Pacific Disease Control And Prevention Vaccine Market, by Indication, 2019-2032 (USD Million)
  • TABLE Latin America Disease Control And Prevention Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Disease Control And Prevention Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Disease Control And Prevention Vaccine Market, by Route of administration, 2019-2032 (USD Million)
  • TABLE Latin America Disease Control And Prevention Vaccine Market, by Indication, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Disease Control And Prevention Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Disease Control And Prevention Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Disease Control And Prevention Vaccine Market, by Route of administration, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Disease Control And Prevention Vaccine Market, by Indication, 2019-2032 (USD Million)

List of Figures

  • FIGURE Disease Control And Prevention Vaccine Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Product Type segment market share analysis, 2023 & 2032
  • FIGURE Product Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Route of administration segment market share analysis, 2023 & 2032
  • FIGURE Route of administration segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indication segment market share analysis, 2023 & 2032
  • FIGURE Indication segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Disease Control And Prevention Vaccine Market share and leading players, 2023
  • FIGURE Europe Disease Control And Prevention Vaccine Market share and leading players, 2023
  • FIGURE Asia Pacific Disease Control And Prevention Vaccine Market share and leading players, 2023
  • FIGURE Latin America Disease Control And Prevention Vaccine Market share and leading players, 2023
  • FIGURE Middle East and Africa Disease Control And Prevention Vaccine Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Disease Control And Prevention Vaccine Market share analysis by country, 2023
  • FIGURE Germany Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Disease Control And Prevention Vaccine Market share analysis by country, 2023
  • FIGURE India Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Disease Control And Prevention Vaccine Market share analysis by country, 2023
  • FIGURE Brazil Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Disease Control And Prevention Vaccine Market share analysis by country, 2023
  • FIGURE Saudi Arabia Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV2201

REPORT HIGHLIGHT

Disease Control And Prevention Vaccine Market size was valued at USD 51,210.3 Million in 2023, expanding at a CAGR of 10.5% from 2024 to 2032.

Immunization is widely recognized as a significant achievement in public health throughout the twentieth century. Vaccines have proven to be highly effective in preventing diseases, saving lives, and reducing healthcare costs. The widespread adoption of vaccination has successfully prevented disability and death in numerous children, leading governments worldwide to prioritize vaccination in their public health services. China, for instance, has effectively controlled infectious diseases through its national immunization program, which is based on vaccination. The Centers for Disease Control and Prevention (CDC) plays a crucial role in recommending and promoting vaccination programs to protect individuals and communities from vaccine-preventable diseases. The CDC provides vaccination guidelines, monitors vaccine safety, conducts research on vaccine effectiveness, and collaborates with other organizations to ensure a comprehensive approach to disease prevention.

Disease Control And Prevention Vaccine Market- Market Dynamics

Rising incidence of infectious diseases worldwide and the adoption of vaccines are anticipated to propel the expansion of the Disease Control and Prevention Vaccine market.

The global incidence of infectious diseases is on the rise, and the use of vaccines is expected to play a significant role in controlling and preventing their spread. Vaccines are crucial in safeguarding public health, and as awareness about their importance increases, there is a growing adoption of vaccination programs worldwide. Governments, healthcare organizations, and individuals are recognizing the value of vaccines in protecting communities from the burden of infectious diseases. Throughout history, infectious diseases have caused immense suffering, both in terms of illness and death. According to the Center for Disease Control and Prevention, there were 10.2 million visits to physician offices for infectious and parasitic diseases, and 3.8 million emergency department visits with these diseases as the primary diagnosis. Ongoing research and development in vaccine technology hold promising prospects for market growth. However, it is important to note that stringent regulatory processes may pose challenges to the expansion of the Disease Control and Prevention Vaccine market.

Disease Control And Prevention Vaccine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.5% over the forecast period (2024-2032)

Based on product type segmentation, Live-attenuated Vaccines was predicted to show maximum market share in the year 2023

Based on Route of administration segmentation, Injectable was the leading type in 2023

Based on Indication segmentation, Infectious Disease was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Disease Control And Prevention Vaccine Market- Segmentation Analysis:

The Global Disease Control And Prevention Vaccine Market is segmented on the basis of Product Type, Route of administration, Indication, and Region.

The market is divided into four categories based on product type: Live-attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines and Toxoid Vaccines. Live-attenuated vaccines dominate a substantial portion of the market. Renowned for their remarkable effectiveness, these vaccines closely mimic natural infections, providing robust and long-lasting immunity.

The market is divided into two categories based on Route of administration: Oral and Injectable. The injectable segment commands a substantial portion of the market. Injectable vaccines are delivered through injections, typically either intramuscularly (IM) or subcutaneously (SC), to stimulate the immune system and initiate an immune response.

The market is divided into two categories based on Indication: Infectious Disease, Cancer and Other Indication. The Infectious Disease segment holds significant sway over the market. Many nations implement immunization programs to control the spread of infectious diseases. These programs often include routine childhood vaccinations and targeted vaccinations for specific populations.

Disease Control And Prevention Vaccine Market- Geographical Insights

Geographically, this market is spread across various regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The market growth is expected to be driven by North America in the forecast period, primarily due to the availability of highly advanced technologies and the increasing development of innovative vaccines. North America, especially the United States, is renowned for its advanced healthcare infrastructure and research capabilities. The region is home to numerous pharmaceutical and biotechnology companies that heavily invest in research and development, leading to the development of cutting-edge technologies for vaccine production. By the end of 2022, the United States is projected to spend USD 4.5 trillion on healthcare, making it the country with the highest overall healthcare expenditure globally. According to the latest data and reports on healthcare in the United States, the country's overall spending in 2021 is estimated to reach USD 4.3 trillion, accounting for 18.5% of its GDP. Europe holds the second-largest region for market growth during the forecast period, primarily due to the increasing disease burden.

Disease Control And Prevention Vaccine Market- Competitive Landscape:

The Disease Control and Prevention Vaccine market encompasses a wide range of vaccines developed by various organizations and companies to combat different diseases. Notable contributors to vaccine advancements include the World Health Organization (WHO), National Institutes of Health (NIH), and private entities. The recent emergence of infectious diseases on an unprecedented scale has presented new challenges for vaccine developers, regulators, health authorities, and political constituencies. The manufacturing and distribution of vaccines are complex processes that require both speed and careful consideration of clinical development, emergency use authorization, vaccine safety monitoring, and surveillance of virus variants. It is crucial to prioritize access to vaccines and vaccination efforts in low- and middle-income countries. While the vaccine industry is smaller compared to the pharmaceutical industry, it is steadily growing. Companies within the vaccine industry engage in research, development, manufacturing, sales, marketing, and distribution of vaccines, with their revenue primarily derived from vaccine product sales.

Recent Development:

In October 2023, the FDA has approved PENBRAYA (meningococcal groups A, B, C, W, and Y vaccine), according to Pfizer Inc. This is the first and only pentavalent vaccine that protects against the most common serogroups that cause meningococcal disease in adolescents and young adults (10-25 years of age). In order to help protect against the five most common meningococcal serogroups that cause the majority of invasive meningococcal disease (IMD) worldwide, PENBRAYA combines the components from two meningococcal vaccines: Nimenrix® (meningococcal groups A, C, W-135, and Y conjugate vaccine) and Trumenba® (meningococcal group B vaccine).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Merck & Co. GlaxoSmithKline plc.

Sanofi, AstraZeneca PLC

Pfizer Inc.

Astellas Pharma Inc.

Sinovac Biotech Ltd.

Daiichi Sankyo

Serum Institute of India Pvt. Ltd.

GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Live-attenuated Vaccines
  • Inactivated Vaccines
  • Recombinant Vaccines
  • Toxoid Vaccines

GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Injectable

GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Infectious Disease
  • Cancer
  • Other Indication

GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Disease Control And Prevention Vaccine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Disease Control And Prevention Vaccine Market Snippet by Product Type
    • 2.1.2. Disease Control And Prevention Vaccine Market Snippet by Route of administration
    • 2.1.3. Disease Control And Prevention Vaccine Market Snippet by Indication
    • 2.1.4. Disease Control And Prevention Vaccine Market Snippet by Country
    • 2.1.5. Disease Control And Prevention Vaccine Market Snippet by Region
  • 2.2. Competitive Insights

3. Disease Control And Prevention Vaccine Key Market Trends

  • 3.1. Disease Control And Prevention Vaccine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Disease Control And Prevention Vaccine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Disease Control And Prevention Vaccine Market Opportunities
  • 3.4. Disease Control And Prevention Vaccine Market Future Trends

4. Disease Control And Prevention Vaccine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Disease Control And Prevention Vaccine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Disease Control And Prevention Vaccine Market Landscape

  • 6.1. Disease Control And Prevention Vaccine Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Disease Control And Prevention Vaccine Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Live-attenuated Vaccines
    • 7.1.3. Inactivated Vaccines
    • 7.1.4. Recombinant Vaccines
    • 7.1.5. Toxoid Vaccines

8. Disease Control And Prevention Vaccine Market - By Route of administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of administration, 2023 & 2032 (%)
    • 8.1.2. Oral
    • 8.1.3. Injectable

9. Disease Control And Prevention Vaccine Market - By Indication

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 9.1.2. Infectious Disease
    • 9.1.3. Cancer
    • 9.1.4. Other Indication

10. Disease Control And Prevention Vaccine Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Disease Control And Prevention Vaccine Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Disease Control And Prevention Vaccine Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Disease Control And Prevention Vaccine Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Disease Control And Prevention Vaccine Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Disease Control And Prevention Vaccine Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Disease Control And Prevention Vaccine Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Merck & Co. GlaxoSmithKline plc.
    • 11.2.2. Sanofi, AstraZeneca PLC
    • 11.2.3. Pfizer Inc.
    • 11.2.4. Astellas Pharma Inc.
    • 11.2.5. Sinovac Biotech Ltd.
    • 11.2.6. Daiichi Sankyo
    • 11.2.7. Serum Institute of India Pvt. Ltd.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us